Faculty profile
David Park
Back to facultyResearch
Read how they describe their research on their University of Ottawa profile.
Latest papers
Loss of PINK1 function promotes mitophagy through effects on oxidative stress and mitochondrial fission.
The Journal of biological chemistry · 2009
Latest funding
- $955,625
Novel pathways underlying degeneration in Parkinson's disease: a focus on Pink1 and LRRK2
CIHR · 2016 · Nominated PI
- $3,499,916
Defining critical pathways for neuronal loss and dysfunction in Parkinsons disease and stroke
CIHR · 2015 · Nominated PI
- $333,000
GBA1 mutations in Parkinson's disease: clinical and biochemical prodrome, risk profile and pathogenetic modelling for therapeutic intervention.
CIHR · 2015 · Nominated PI
1 publications.
Loss of PINK1 function promotes mitophagy through effects on oxidative stress and mitochondrial fission.
Dagda RK, Cherra SJ, Kulich SM, Tandon A, Park D, Chu CT
Novel pathways underlying degeneration in Parkinson's disease: a focus on Pink1 and LRRK2
Principal investigators: Park, David S
Keywords: Calcium Regulation; Lrrk2; Neurodegeneration; Parkinson'S Disease'; Phagocytosis; Pink1; Wave2
Defining critical pathways for neuronal loss and dysfunction in Parkinsons disease and stroke
Principal investigators: Park, David S
Keywords: Animal Models; Mitochondria; Neurodegeneration; Neuronal Injury; Parkinson'S Disease; Stroke
GBA1 mutations in Parkinson's disease: clinical and biochemical prodrome, risk profile and pathogenetic modelling for therapeutic intervention.
Principal investigators: Park, David S
Keywords: Alpha-Synuclein; Biomarkers; Chaperones; Clinical Cohort; Gba1; Glucocerebrosidase; Lysosome; Parkinson'S Disease'; Prodome; Toxins
Cellular Bioenergetics in Neurodegenerative Diseases: A system-based pathway and target analysis.
Principal investigators: Park, David S
Keywords: Bioenergetics; C. Elegans; Computational Modelling; D. Melanogaster; Disease Mechanisms; Hight-Throughput Drug Screen; Mitochondria; Second-Hit Hypothesis; Therapeutics; Transgenic Mouse Models
Targeting glucocerebrosidase for disease-modifying treatments in Parkinson disease
Principal investigators: Park, David S
Keywords: Parkinson Disease
Insights into Parkinson's disease, Crohn's disease, and leprosy: a common role for LRRK2
Principal investigators: Park, David S; Gibbings, Derrick J; Hayley, Shawn P; Philpott, Dana J; Rioux, John D; Schlossmacher, Michael G; Schurr, Erwin A
Keywords: Autophagy; Chron'S Disease; Genetics; Immune Function; Immunity; Leprosy; Lrrk2; Parkinson'S Disease; Rna Processing
Canadian Stroke Network (2006 Renewal Competition)
Principal investigators: Hakim, Antoine
Insights into Parkinson's disease, Crohn's disease, and leprosy: a common role for LRRK2
Principal investigators: Park, David S; Gibbings, Derrick J; Philpott, Dana J; Schlossmacher, Michael G; Schurr, Erwin A
Keywords: Autophagy; Crohn'S Disease; Genetics; Immune Function; Immunity; Leprosy; Lrrk2; Parkinson'S Disease; Rna Processing
Mechanisms of DJ-1 in an aging model of PD
Principal investigators: Park, David S
Keywords: Aging; Cell Death; Dj-1; Dopamine; Neurons; Parkinson Disease
Understanding the role of DJ-1 in Parkinson's disease: Role of VDAC1
Principal investigators: Hewitt, Sarah J
Keywords: Confocal Microscopy; Dj-1; Mitochondria; Neurodegeneration; Oxidative Stress; Parkinson'S Disease; Transgenic Models; Western Blot
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.
Profile data last refreshed on September 25, 2026 from the university directory, publication records and CIHR, NSERC and SSHRC funding.